GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (GREY:PMKIF) » Definitions » Cyclically Adjusted PS Ratio

PMKIF (PT Merck Tbk) Cyclically Adjusted PS Ratio : (As of Sep. 24, 2024)


View and export this data going back to 2012. Start your Free Trial

What is PT Merck Tbk Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


PT Merck Tbk Cyclically Adjusted PS Ratio Historical Data

The historical data trend for PT Merck Tbk's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Merck Tbk Cyclically Adjusted PS Ratio Chart

PT Merck Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.21 1.46 1.66 2.07 1.82

PT Merck Tbk Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.12 2.14 1.82 1.73 1.76

Competitive Comparison of PT Merck Tbk's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, PT Merck Tbk's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Merck Tbk's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Merck Tbk's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PT Merck Tbk's Cyclically Adjusted PS Ratio falls into.



PT Merck Tbk Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

PT Merck Tbk's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, PT Merck Tbk's adjusted Revenue per Share data for the three months ended in Jun. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=0.032/130.7916*130.7916
=0.032

Current CPI (Jun. 2024) = 130.7916.

PT Merck Tbk Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201409 0.055 94.576 0.076
201412 0.040 98.819 0.053
201503 0.358 98.388 0.476
201506 0.043 99.766 0.056
201509 0.034 101.037 0.044
201512 0.037 102.133 0.047
201603 0.052 102.764 0.066
201606 0.046 103.212 0.058
201609 0.039 104.142 0.049
201612 0.038 105.222 0.047
201703 0.053 106.476 0.065
201706 0.049 107.722 0.059
201709 0.048 108.020 0.058
201712 -0.052 109.017 -0.062
201803 0.023 110.097 0.027
201806 0.024 111.085 0.028
201809 0.025 111.135 0.029
201812 0.023 112.430 0.027
201903 0.026 112.829 0.030
201906 0.024 114.730 0.027
201909 0.029 114.905 0.033
201912 0.040 115.486 0.045
202003 0.022 116.252 0.025
202006 0.019 116.630 0.021
202009 0.023 116.397 0.026
202012 0.034 117.318 0.038
202103 0.039 117.840 0.043
202106 0.039 118.184 0.043
202109 0.044 118.262 0.049
202112 0.044 119.516 0.048
202203 0.047 120.948 0.051
202206 0.045 123.322 0.048
202209 0.039 125.298 0.041
202212 0.036 126.098 0.037
202303 0.039 126.953 0.040
202306 0.035 127.663 0.036
202309 0.041 128.151 0.042
202312 0.026 129.395 0.026
202403 0.036 130.607 0.036
202406 0.032 130.792 0.032

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PT Merck Tbk  (GREY:PMKIF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


PT Merck Tbk Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of PT Merck Tbk's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Merck Tbk Business Description

Traded in Other Exchanges
Address
Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines to treat cancer, multiple sclerosis, infertility, growth disorders, and cardiovascular and metabolic diseases, as well as chronic diseases.

PT Merck Tbk Headlines

No Headlines